Learn more about Lindus Health from our blog page. Our posts cover an array of topics from clinical developments to diversity.
Every cancer case in a large screening trial must be fully documented, with complete diagnostic, staging, treatment, and outcome data. Losing even a small number of cases to incomplete follow-up can undermine the statistical power the entire study was designed to achieve. The operational model has to be built around preventing that from the start.
The digital transformation of the fertility space has brought us everything from period tracking apps to FDA-cleared digital contraceptives. Yet these tools are often grouped together under broad categories that obscure critical differences in their purpose and effectiveness.
Consumer health is a $6.3 trillion mainstream market with consumers prioritizing solutions that help them feel and look better and live longer. Yet in this crowded, fast-moving space, one principle stands above all others: trust is the foundation of strong consumer health brands.
Ovarian cancer remains one of the most lethal gynecological cancers, largely because diagnosis often comes too late. Around 70% of cases are detected at an advanced stage, with approximately 300,000 new cases each year.
Last week, the FDA published draft guidance designed to facilitate the use of Bayesian methodologies in clinical trials of drugs and biologics. It is a welcome step toward faster, more practical clinical development that puts patients first, especially those for whom a clinical trial is often their best hope.
Listen to episode 3 of our podcast "Off Protocol", where guest host Zara Liew sits down with Dr Michelle Griffin to discuss an area of women’s health that has long been overlooked: heavy menstrual bleeding.
Discover the ins and outs of GLP-1 receptor agonists in this comprehensive article.